Objective: There have been a large number of studies that have investigated the relationship between outcomes and provider volume for a wide variety of medical conditions and surgical conditions. The objective of this study was to explore the relation between hospital volume and riskadjusted mortality following percutaneous coronary intervention between 2003 and 2004 in Korea. Methods: This is a retrospective analysis of database in National Health Insurance Review & Assessment Service and Korean National Statistical Office. The study data set confined to the ICD-10 diagnosis and procedure codes that were recorded in the National Health Insurance Review Agency. Risk modeling was performed through logistic regression and validated with cross-validation. The statistical performance of the developed model was evaluated using c-statistics, R 2 , and Hosmer-Lemeshow statistic. Crude and risk-adjusted 30-day mortality was evaluated among patients who underwent Percutaneous Coronary Intervention (PCI) between 2003 and 2004 at low (less 200 cases/year), medium (200~399 cases/year), and high (400 cases or more/year) PCI volume hospitals. Results: The final risk-adjustment model consisted of ten risk factors for 30-day mortality. These factors were found to have statistically significant effects on patient mortality. The c-statistic and Hosmer-Lemeshow χ 2 goodness-of-fit test and the model's performance were good [R 2 =0.147, c-statistic 0.823, 4.1037 (p=0.8476)]. A total number of 60 low-volume hospitals (9.071 patients) and 27 medium-volume hospitals (15.623 patients) and 15 high-volume hospitals (19.669 patients) were included. Crude 30-day mortality rate was 1.4%, 1.1%, and 1.0% (p=0.0106) in each volume hospitals. But risk-adjusted mortality rate was not significantly different among three groups (1.3%, 1.0%, and 1.1% in each volume hospitals). Conclusion: Although we found a significant different crude 30-day mortality rates according to hospital PCI volume, but did not find a relationship between hospital volume and 30-day risk-adjusted mortality rates following PCI in Korea. (Anadolu Kardiyol Derg 2013; 13: 237-42) 
Introduction
In general, it is believed that technically challenging manual procedures will result in a better outcome if it is performed by skilled specialists at high-volume institutions. Previous studies also have demonstrated above suggestions in many surgical procedures, such as coronary artery bypass graft, pancreatic and thoracic surgery (1) (2) (3) . In cardiology, the relationship between hospital percutaneous coronary intervention (PCI) volume and in-hospital mortality has been widely investigated (4, 5) . There is some evidence that the disparity in outcomes of PCI between high-and low-volume hospitals has narrowed over time (6) . But a recent meta-analysis reported this relationship has not attenuated over time (7) . Most of the studies related with hospital volume and outcome originated from USA hospitals. The number of studies from outside the USA was too small to explore the similarity of the effect across countries. Only a couple of studies originated from Japan (8) (9) (10) . In addition, it is unclear whether previous results can be generalized to other countries outside the USA. So we tried to evaluate the relationship between hospital volume and risk-adjusted mortality rate following PCI in Korea.
Methods Database
We analyzed data from the Korea National Health Insurance Review & Assessment Service and Korean National Statistical Office between 2003 and 2004 for this study. We used American Agency for Healthcare Research and Quality (AHRQ) for guidance of our study (11) . So we defined general patient information and all the International Statistical Classification of Diseases, Tenth Revision (ICD-10) diagnosis and procedure codes. In the present study, PCI patients were defined as the ones who were diagnosed with such codes as M6551, M6552, M6561, M6562, M6563, M6564, M6571, and M6572. We excluded patients under the age of 18 and neonatal or obstetric admissions in order to restrict our evaluation to the use of PCI in a typical adult population. We consulted with five expert interventional cardiologists working in university hospitals to reduce selection bias of risk factors.
Hospital PCI volume groups
To assess the validity of the annual hospital PCI volume threshold of 400 cases recommended by ACC/AHA PCI guidelines (12) and by the Leapfrog Group (13) we divided above data into three groups. Hospitals with fewer than 400 annual cases were divided into those below 200 cases (hereafter referred to as low-volume) and 200 to 399 cases (medium-volume). Hospitals with above 400 annual cases were classified as high-volume hospitals.
Definition of death
Major cardiac adverse events frequently occurred within one month of PCI so we investigated 30 day mortality rates (14) and we compared the deceased patient's biological information with data from the Korean National Statistical Office. We included only patients expired in hospital and excluded expired out of hospital or unidentified death in our analysis.
Variables for analysis
Patient characteristics such as admission source (referral, emergency medical services or others), admission type (outpatient or emergency room) and presence of diabetes mellitus, hypertension, hyperlipidemia, congestive heart failure (CHF), cardiogenic shock, arrhythmia, chronic obstructive lung disease (COPD), renal disease, peripheral vascular disease, stroke, multivessel procedure, stent deployment and the type of coronary artery disease (stable angina, unstable angina, myocardial infarction) were analyzed.
Statistical analysis
The SAS 9.1 statistical software (SAS Institute Inc., Cary, NC, USA) was used to perform the statistical analysis of the data. Patients biological, admission and comorbidity information were compared across the three hospital PCI volume groups using global chi-square analyses for categorical variables and riskadjustment model. We performed univariate logistic regression analysis to evaluate risk factors that influence 30-day mortality. Those variables that were significant predictors on univariate analysis were entered into the multivariate logistic regression model. We calculated adjusted mortality rate and compared relationship between severity determining risk factors and hos- Odds ratios with 95% confidence intervals were calculated for each covariate. Statistical significance was defined as p values <0.05.
Results
Our analysis involved 44.363 patients. The mean age of the patient population was 63.8 years. 64.9 % were men and 35.1% were women. Clinical characteristics and variables included in our study are presented in Table 1 . There were 102 hospitals performing PCI during the study period. A total of 60, 27 and 15 hospitals were in low, medium and high-volume hospital groups. 9.071 (20.5%) patients were treated at high-volume hospitals, 15.623 (35.2%) at medium-volume hospital and 19.669 (44.3%) at low-volume hospital. Mean age, admission type, diabetes, hypertension, hyperlipidemia, unstable angina, acute myocardial infarction (AMI), congestive heart failure (CHF), arrhythmia, chronic obstructive lung disease (COPD), renal disease, peripheral vascular disease, stroke, multivessel procedure and stent deployment to be significant predictors for 30-day mortality (Table 2 ). These significant risk factors entered into the multivariate logistic regression analysis. The logistic-regression model revealed age, emergency visitors, AMI, CHF, arrhythmia, COPD, renal disease, stroke, multivessel procedure and stent deployment to be significant predictors (Table 3) . HosmerLemeshow χ 2 goodness-of-fit test showed a p value of 0.8476 and good-model quality. The Cochran-Armitage trend test (p=0.0106) showed crude 30-day mortality rates declined with increasing volume and rates were 1.4% in low, 1.1% in medium and 1.0% in high volume hospitals, p<0.05. When we considered crude 30-day mortality rates patients treated at low-volume hospitals had significantly higher mortality rates than those treated in medium-volume (1.4% vs. 1.1%, p<0.05) or high-volume hospitals (1.4% vs. 1.0%, p<0.05). But we could not find any relationship between hospital volume and 30-day risk-adjusted mortality rates (1.3% in low, 1.0% in medium and 1.1% in high volume hospitals) following PCI in Korea (Table 4) .
Discussion
The use of administrative data to identify inpatient complications is technically feasible and inexpensive but unproven as a quality measure. Weingart et al. (15) suggested that screening administrative data may offer an efficient approach for identifying potentially problematic cases for physician review.
Sundararajan et al. (16) said ICD-10 Charlson comorbidity coding algorithm had a good to excellent discrimination in their ability to predict mortality. So we used ICD-10 diagnosis and procedure codes. During the past 20 years researchers have focused on measuring and explaining the association between patient outcomes and the volume of health services provided by hospitals and physicians (17) . Mant studies have documented that higher volume is associated with better outcomes. They suggested this results may be because physicians develop more effective skills if they treat more patients (practice makes perfect) and physicians and hospitals achieving better outcomes receive more referrals and thus accrue larger volumes (selective referral) (18, 19) . That is patients treated at high-volume hospitals encounter a lower risk of mortality when compared with patients treated at low-volume hospitals. But Burton et al. (20) AMI -acute myocardial infarction, CHF -congestive heart failure, CI -confidence interval, COPD -chronic obstructive pulmonary disease, OR -odds ratio, , PCI -percutaneous coronary intervention (4) suggested that there is narrowing difference in mortality rates between high-and medium-volume hospitals due to accumulating experience with PCI procedures among surgeons, especially those serving in medium-PCI volume hospitals. In our study, crude 30-day mortality rate was 1.1% (Table 2) . Zahn et al. (24) reported an in-hospital mortality of 1.85% in hospitals belonging to the lowest PCI volume quartile and 1.21% in the highest quartile. But technological improvement of PCI, PCI instruments and new pharmacologic therapies in recent years it might have reduced mortality. We used risk-adjusted mortality rate in this study. This equation is composed of actual number of deaths, predicted number of deaths and overall mortality rate. The statistical performance of the developed model was evaluated using c-statistic, R 2 , Hosmer-Lemeshow statistic. They showed good model quality. Future studies of the PCI volume-outcome association will need to determine the process through which volume and outcomes are linked and to identify recent year's trends.
Study limitations
Our analysis used ICD-10 diagnosis and procedure codes data, and thus may not had captured the full clinical detail of a patient's risk profile. In particular, no data regarding target coronary vessel characteristics, stent types, left ventricular ejection fraction or Killip class, type of arrhythmias, type of peripheral vascular disease, and use of antiplatelet agents were precisely recorded which makes the analysis incomplete. We evaluated in-hospital mortality alone and could not assess other patient's outcomes, including periprocedural complications, repeat revascularization rates, or longer-term outcomes. Another limitation is we did not track the experience of individual operators. So we cannot account for the influence of individual operator PCI volume on the association between hospital PCI volume and mortality. Although we had finely analyzed database of Korean National Statistical Office, we included only patients deceased in hospital and excluded deceased out of hospital or unidentified death in our analysis.
Conclusion
Although we could find significant relationship between different crude 30-day mortality rates according to hospital PCI volume, we could not find a relationship between hospital volume and 30-day risk-adjusted mortality rates following PCI in Korea. Table 4 . 30-day mortality rates of patients undergoing PCI at low-volume (<200 cases/year), medium-volume (200~399cases/year) and highvolume (>400 cases/year) hospitals
